• Profile
Close

Lack of long-term add-on effect by montelukast in postoperative chronic rhinosinusitis patients with nasal polyps

The Laryngoscope Nov 22, 2017

Van Gerven L, et al. - The purpose of this trial was to investigate the efficacy of leukotriene antagonists in chronic rhinosinusitis (CRS). Additionally, it also incorporated the assessment of montelukast as an add-on treatment to intranasal corticosteroids (INCS) in a postoperative setting. The yielded data did not recommend the addition of montelukast to INCS for the treatment of postoperative CRS with nasal polyp (CRSwNP) patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay